A quality defect was found: an out‑of‑specification result for the colour parameter in a parenterally administered medicinal product, which entails a potential risk to patients’ health or life. Potential effects: complications after intravenous or intramuscular administration, lack of treatment safety.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 10719; check the batch number on the packaging and, if you have it, return the product to the pharmacy or the marketing authorisation holder; if the withdrawn batch h...
The Chief Pharmaceutical Inspector withdrew batch 10719 of Biodacyna from the market throughout the country and granted the decision immediate enforceability, obliging the marketing authorisation hold...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related